BASF evaluates $500M MDI investment in India
BASF evaluates $500M MDI investment in India. The German chemical giant is assessing a major investment in Methylene Diphenyl Diisocyanate (MDI) manufacturing in India. This move could strengthen its footprint in the growing Indian specialty chemicals market. $500M outlay under evaluation signals long-term confidence.
📊 STOCKS: $BASF | 🏢 SECTOR: CapitalMarkets | #MEDIUMIMPACT #Investment
This brief is AI-generated from public news sources for informational purposes only. Not investment advice. Always consult a SEBI-registered advisor before trading.